Responsiveness of metastatic basal-cell carcinoma to chemotherapy. A case report
- 1 November 1983
- Vol. 52 (9) , 1583-1585
- https://doi.org/10.1002/1097-0142(19831101)52:9<1583::aid-cncr2820520907>3.0.co;2-g
Abstract
Basal cell carcinoma normally causes major morbidity only by direct extension of the tumor into adjacent tissues. Occasionally the tumor will metastasize to distant sites such as the lungs, the bones, regional lymph nodes, and the abdominal viscera. Over 100 cases of this disseminated disease are reported in the literature. Once a tumor has metastasized beyond the regional lymph nodes it is uniformly fatal. This article reports a case of basal cell carcinoma, metastatic to the lung, which was successfully treated with cisplatin. Three other cases treated similarly are reviewed, and the prospects for treatment of advanced basal cell carcinomas with chemotherapy are discussed.This publication has 10 references indexed in Scilit:
- Metastatic basal cell carcinomaJournal of Surgical Oncology, 1980
- Metastatic basal cell carcinoma: A clinicopathologic study of seventeen casesCancer, 1980
- Metastatic basal cell carcinoma: report of a case responding to chemotherapyPublished by Oxford University Press (OUP) ,1980
- CLINICAL PHASE I-II STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) GIVEN BY CONTINUOUS IV INFUSION1978
- Basal Cell Carcinoma With Bony Metastases Producing MyelofibrosisArchives of Dermatology, 1977
- Metastatic Basal Cell CarcinomaArchives of Dermatology, 1977
- Metastatic basal cell carcinoma: review, pathogenesis, and report of two casesArchives of Dermatology, 1977
- Metastatic basal cell carcinoma: Review, report of a case, and chemotherapyCancer, 1974
- Basal cell carcinoma with metastasis to bone.Report of two casesCancer, 1967